Salles, Gilles http://orcid.org/0000-0002-9541-8666
Barrett, Martin
Foà, Robin
Maurer, Joerg
O’Brien, Susan
Valente, Nancy
Wenger, Michael
Maloney, David G.
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd (Support for third-party writing assistance for this manuscript)
Article History
Received: 14 July 2017
First Online: 5 October 2017
Compliance with Ethics Guidelines
: The information reported in this review is derived from previously conducted studies: this does not include any new studies of human or animal subjects performed by any of the authors. All authors had full access to the information included in this review and take complete responsibility for the integrity of the data discussions.
: Martin Barrett is an employee of Roche Products Ltd. and holds share options. Robin Foà has received honoraria from F. Hoffmann-La Roche Ltd. Joerg Maurer is an employee of F. Hoffmann-La Roche Ltd. and holds share options. Michael Wenger is an employee of F. Hoffmann-La Roche Ltd. and holds share options. David G. Maloney has nothing to disclose. Nancy Valente is an employee of Genentech Inc. and holds share options. Gilles Salles has received research and travel grant support and honoraria from F. Hoffmann-la Roche Ltd., and honoraria from Amgen, BMS, Celgene, Gilead, Janssen, Kite, Merck, Morphosys, Novartis, and Servier. Susan O’Brien has received research grant support from ProNAI, Regeneron, and Acerta, and consultant/research support from Gilead, Pharmacyclics, TG Therapeutics, and Pfizer, and has acted as a consultant for Amgen, Astellas, Celgene, GlaxoSmithKline, Janssen Oncology, Aptose Biosciences Inc., Vaniam Group LLC, Abbvie, Sunesis, and Alexion.
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.